Literature DB >> 12835366

Effect of innappropriate naltrexone use in a heroin misuser.

S H Boyce1, P A R Armstrong, J Stevenson.   

Abstract

Naltrexone is a long acting opioid receptor antagonist used in controlled opioid withdrawal drug programmes. When taken by an opioid dependent patient an acute withdrawal reaction will be precipitated. The case is presented where a known opioid drug misuser inadvertently ingested naltrexone in conjunction with heroin resulting in severe agitation, requiring heavy sedation followed by general anaesthesia to enable investigation and management of his clinical condition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835366      PMCID: PMC1726126          DOI: 10.1136/emj.20.4.381

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  6 in total

1.  Transport of Maternally Administered Pharmaceutical Agents Across the Placental Barrier In Vitro.

Authors:  Rajeendra L Pemathilaka; Nima Alimoradi; David E Reynolds; Nicole N Hashemi
Journal:  ACS Appl Bio Mater       Date:  2022-04-05

2.  Role of Benzodiazepines in the management of agitation due to inappropriate use of naltrexone.

Authors:  Ali Mohammad Sabzghabaee; Nastaran Eizadi-Mood; Farzad Gheshlaghi; Azam Javani; Shahin Shirani; Safieh Aghaabdollahian
Journal:  Iran J Nurs Midwifery Res       Date:  2012-07

3.  The frequency of agitation due to inappropriate use of naltrexone in addicts.

Authors:  Sima Siadat; Nastaran Eizadi-Mood; Ali Mohammad Sabzghabaee; Farzad Gheshlaghi; Ahmad Yaraghi
Journal:  Adv Biomed Res       Date:  2014-12-06

4.  Acute Myocardial Infarction following Naltrexone Consumption; a Case Report.

Authors:  Bita Dadpour; Arash Gholoobi; Shahrad Tajoddini; Amir Habibi
Journal:  Emerg (Tehran)       Date:  2017-01-14

Review 5.  Naltrexone Implant for Opioid Use Disorder.

Authors:  Amber N Edinoff; Catherine A Nix; Claudia V Orellana; Samantha M StPierre; Erin A Crane; Blaine T Bulloch; Elyse M Cornett; Rachel L Kozinn; Adam M Kaye; Kevin S Murnane; Alan D Kaye
Journal:  Neurol Int       Date:  2021-12-30

6.  Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report.

Authors:  Laura M Szczesniak; Vincent J Calleo; Ross W Sullivan
Journal:  Harm Reduct J       Date:  2020-10-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.